Cargando…

Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020

BACKGROUND: To track the European spread of SARS-CoV-2, decentralized testing became necessary and test capacity needed to be expanded outside reference laboratories rapidly. METHODS: We assessed via an online questionnaire the preparedness of European hospital laboratories for detection of SARS-CoV...

Descripción completa

Detalles Bibliográficos
Autores principales: Matheeussen, Veerle, Loens, Katherine, Lammens, Christine, Vilken, Tuba, Koopmans, Marion, Goossens, Herman, Ieven, Margareta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227504/
https://www.ncbi.nlm.nih.gov/pubmed/32422569
http://dx.doi.org/10.1016/j.jcv.2020.104432
_version_ 1783534509711425536
author Matheeussen, Veerle
Loens, Katherine
Lammens, Christine
Vilken, Tuba
Koopmans, Marion
Goossens, Herman
Ieven, Margareta
author_facet Matheeussen, Veerle
Loens, Katherine
Lammens, Christine
Vilken, Tuba
Koopmans, Marion
Goossens, Herman
Ieven, Margareta
author_sort Matheeussen, Veerle
collection PubMed
description BACKGROUND: To track the European spread of SARS-CoV-2, decentralized testing became necessary and test capacity needed to be expanded outside reference laboratories rapidly. METHODS: We assessed via an online questionnaire the preparedness of European hospital laboratories for detection of SARS-CoV-2 and listed the main drawbacks for implementation. RESULTS: Forty-five percent of the surveyed labs had a test in place by March 26th which is well into the first wave of the pandemic in most countries. CONCLUSIONS: The main implementation barriers for introduction of a SARSCoV-2 molecular assay in European diagnostic laboratories were availability of positive controls and a specificity panel.
format Online
Article
Text
id pubmed-7227504
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-72275042020-05-18 Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020 Matheeussen, Veerle Loens, Katherine Lammens, Christine Vilken, Tuba Koopmans, Marion Goossens, Herman Ieven, Margareta J Clin Virol Article BACKGROUND: To track the European spread of SARS-CoV-2, decentralized testing became necessary and test capacity needed to be expanded outside reference laboratories rapidly. METHODS: We assessed via an online questionnaire the preparedness of European hospital laboratories for detection of SARS-CoV-2 and listed the main drawbacks for implementation. RESULTS: Forty-five percent of the surveyed labs had a test in place by March 26th which is well into the first wave of the pandemic in most countries. CONCLUSIONS: The main implementation barriers for introduction of a SARSCoV-2 molecular assay in European diagnostic laboratories were availability of positive controls and a specificity panel. Elsevier B.V. 2020-07 2020-05-15 /pmc/articles/PMC7227504/ /pubmed/32422569 http://dx.doi.org/10.1016/j.jcv.2020.104432 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Matheeussen, Veerle
Loens, Katherine
Lammens, Christine
Vilken, Tuba
Koopmans, Marion
Goossens, Herman
Ieven, Margareta
Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020
title Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020
title_full Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020
title_fullStr Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020
title_full_unstemmed Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020
title_short Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020
title_sort preparedness of european diagnostic microbiology labs for detection of sars-cov-2, march 2020
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227504/
https://www.ncbi.nlm.nih.gov/pubmed/32422569
http://dx.doi.org/10.1016/j.jcv.2020.104432
work_keys_str_mv AT matheeussenveerle preparednessofeuropeandiagnosticmicrobiologylabsfordetectionofsarscov2march2020
AT loenskatherine preparednessofeuropeandiagnosticmicrobiologylabsfordetectionofsarscov2march2020
AT lammenschristine preparednessofeuropeandiagnosticmicrobiologylabsfordetectionofsarscov2march2020
AT vilkentuba preparednessofeuropeandiagnosticmicrobiologylabsfordetectionofsarscov2march2020
AT koopmansmarion preparednessofeuropeandiagnosticmicrobiologylabsfordetectionofsarscov2march2020
AT goossensherman preparednessofeuropeandiagnosticmicrobiologylabsfordetectionofsarscov2march2020
AT ievenmargareta preparednessofeuropeandiagnosticmicrobiologylabsfordetectionofsarscov2march2020
AT preparednessofeuropeandiagnosticmicrobiologylabsfordetectionofsarscov2march2020